Homeopathy in cancer

Individualized homeopathy as additive to standard care in cancer patients: an open observational pilot study

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/05/004591

Enrollment

Registered

2014-05-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cancer

Interventions

Intervention1: Individualized homeopathic medicines in 50 millesimal potencies: A single medicated cane sugar globules of poppy seed size (no. 10) dissolved in 50 ml distilled water with addition of 2

Eligibility

Inclusion criteria

Inclusion criteria: Patients older than 18 years and of both sexes who suffered from a verified tumor disease, taking standard care (chemotherapy, radiotherapy etc.), and gave informed consent to participation.

Exclusion criteria

Exclusion criteria: Patients who were presently using homeopathy, who were too unwell to take part, refused informed consent, suffering from any other systemic infections or diseases or congenital anomalies affecting quality of life, vital organ failure

Design outcomes

Primary

Measure	Time frame
Functional Assessment of Cancer Therapy - General (FACT-G)and Functional Assessment of Chronic Illness Therapy - Spiritual Wellbeing (FACIT-Sp)Timepoint: 6 months	—

Secondary

Measure	Time frame
Hospital Anxiety and Depression Scale (HADS)Timepoint: 6 months;Multidimensional Fatigue Inventory (MFI)Timepoint: 6 months	—

Countries

India

Contacts

Public ContactShubhamoy Ghosh

Mahsh Bhattacharyya Homeopathic Medical College and Hospital

shubhamoy67@gmail.com03326774449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026